160 related articles for article (PubMed ID: 23882001)
1. Drug trade bodies rally patient groups to deflect calls for full trial data.
O'Dowd A
BMJ; 2013 Jul; 347():f4702. PubMed ID: 23882001
[No Abstract] [Full Text] [Related]
2. Silence is not the best medicine: requiring disclosure of clinical trial data for abandoned drugs.
Powell B
J Leg Med; 2012 Oct; 33(4):571-92. PubMed ID: 23216153
[No Abstract] [Full Text] [Related]
3. FDA given new powers over data reporting to national clinical trials registry.
Roehr B
BMJ; 2012 Oct; 345():e6629. PubMed ID: 23033375
[No Abstract] [Full Text] [Related]
4. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
Cohen K; Cormier JW; Davar MV
J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261
[No Abstract] [Full Text] [Related]
5. Glaxo agrees to post results of drug trials on web site.
Harris G
N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364
[No Abstract] [Full Text] [Related]
6. Drugmakers prefer silence on test data; firms violate US law by not registering trials.
Vedantam S
Washington Post; 2004 Jul; ():A1, A4. PubMed ID: 15290815
[No Abstract] [Full Text] [Related]
7. Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act.
Logvinov I
Contemp Clin Trials; 2014 Mar; 37(2):219-24. PubMed ID: 24440100
[TBL] [Abstract][Full Text] [Related]
8. Out in the open.
Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
[No Abstract] [Full Text] [Related]
9. Expose your clinical thinking.
Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286628
[No Abstract] [Full Text] [Related]
10. Sense About Science charity joins fight against bid to prevent transparency of trials.
Wise J
BMJ; 2015 Jun; 350():h3428. PubMed ID: 26109395
[No Abstract] [Full Text] [Related]
11. Best-kept secrets.
Nat Biotechnol; 2014 Jun; 32(6):499. PubMed ID: 24911473
[No Abstract] [Full Text] [Related]
12. FDA signals it's open to drug trials that shift midcourse.
Mathews AW
Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
[No Abstract] [Full Text] [Related]
13. Servier found to have breached industry code over disclosure of trial results.
Wise J
BMJ; 2014 Sep; 349():g5534. PubMed ID: 25192751
[No Abstract] [Full Text] [Related]
14. Clinical trial registries and clinical trial result posting: new paradigm for medical writers.
Foote M
Biotechnol Annu Rev; 2006; 12():379-86. PubMed ID: 17045200
[TBL] [Abstract][Full Text] [Related]
15. IRBs and monitoring the safety of clinical trials.
Maloney DM
Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095
[No Abstract] [Full Text] [Related]
16. Congress may force drug firms to reveal clinical trial data.
Check E
Nature; 2004 Sep; 431(7006):232. PubMed ID: 15371992
[No Abstract] [Full Text] [Related]
17. Despite vow, drug makers still withhold data.
Berenson A
N Y Times Web; 2005 May; ():A1, C3. PubMed ID: 15952254
[No Abstract] [Full Text] [Related]
18. Drug-company data vaults to be opened.
Cressey D
Nature; 2013 Mar; 495(7442):419-20. PubMed ID: 23538802
[No Abstract] [Full Text] [Related]
19. Transparency battle resurfaces as EU trial revamp wraps up.
Holmes D
Nat Med; 2013 Jul; 19(7):797. PubMed ID: 23836204
[No Abstract] [Full Text] [Related]
20. Safety panel backs principle of gene-therapy trials.
Check E
Nature; 2002 Dec; 420(6916):595. PubMed ID: 12478252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
